Dr. Newcorn is a professor of psychiatry and pediatrics, director of the Division of ADHD and Learning Disorders at Icahn School of Medicine at Mount Sinai.

His latest research focuses on the clinical and neurobiological basis for differential response to ADHD treatments, using data collected from clinical, pharmacogenetic, and fMRI measures, as well as the neurobiological basis of substance abuse risk in individuals with ADHD.

Alexandra Philipsen, MD. Since 2018 Director and W3 Professor of the Department of Psychiatry and Psychotherapy, University of Bonn. Since 2021 Deputy Medical Director of the University Hospital Bonn. 2014-2017 Director and W3 Professor of the Dept. of Psychiatry and Psychotherapy, Karl Jaspers Klinik, European Medical School, Oldenburg-Groningen.

2009-2014 Executive Senior Physician, Department of Psychiatry and Psychotherapy, University of Freiburg. 2009 Habilitation "on the etiology, symptomatology and therapy of attention-deficit/hyperactivity disorder in adults". 1999 Dr. med. "Botulinum toxin A as a new therapy option in neuropaediatrics, University of Freiburg.

Supervisor for cognitive behavior therapy, dialectical behavior therapy. Scientific focus: translational therapy research on attention and emotion regulation, development and evaluation of pharmacological and non-pharmacological treatments for ADHD in adults. Clinical focus: diagnosis and treatment of the entire spectrum of mental disorders, especially affective disorders such as depression, stress-associated disorders, ADHD in adulthood and personality disorders, crisis intervention and suicidality. Scientific advisor of ADHS-Deutschland (https://adhs-deutschland.de/Home.aspx), member of the steering board of the German ADHD Network (www.zentrales-adhs-netz.de).

Prof. Dr. rer. medic. Anja Görtz‐Dorten, Dipl.‐Psych., Dipl.‐Heilpäd.

Graduation in special education (Dipl.-Heilpäd.) 1994 (University of Applied Sciences Cologne); license in Child and Adolescent Psychotherapy, 1999; graduation in Psychology (Dipl.-Psych.) 2000 (University Düsseldorf); PhD 2005 (University of Cologne); Habilitation 2014 (University of Cologne); adjunct Professor at the Medical Faculty and the Faculty of Human Sciences of the University of Cologne 2019; Head of the outpatient clinic and the research department at the Center for Child and Adolescent Cognitive Behavior Therapy (CeKiP) and Supervisor in Cognitive Behavior Therapy.

Member of the German Conduct Disorders Guidelines Group.

Research in development and evaluation of assessment instruments of mental disorders and personalized modular cognitive-behavioral treatment programs including digitally supported assessment and intervention for children and adolescents with mental disorders.

Emily Simonoff MD, FRCPsych
Professor of Child and Adolescent Psychiatry & Head of Department Director, King’s Maudsley Partnership for Children and Young People King’s College London, Institute of Psychiatry, Psychology and Neuroscience

Emily Simonoff is Professor of Child and Adolescent Psychiatry at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London, where she is also head of the Department and Director of the King’s Maudsley Partnership for Children and Young People. She is also academic lead for the Child and Adolescent Mental Health Services Clinical Academic Group at the South London and Maudsley Foundation Trust. Emily’s research and clinical focus is on neurodevelopmental disorders in children and young people and their overlap with other mental disorders. She is a UK National Institute of Health Research Senior Investigator. She was the Senior Clinical Advisor to the National Institute of Health and Clinical Excellence (NICE) on the 2018 ADHD guidelines and was a member of the ICHOM Standard Set for Neurodevelopmental Disorders Advisory Group. She chaired the European ADHD Guidelines Group from 2014 to 2022/ Emily’s interests span a range of neurodevelopmental disorders. She has also been a member of the two NICE Guidelines groups for autism and a member of the Strategy Board for the UK National Autism Project. She has been a member of the Westminster Commission for Autism and has given evidence to the All-Party Parliamentary Group on Autism. Emily receives research funding related to autism from the Medical Research Council, Economic and Social Research Council, National Institute of Health and Research EU Innovative Medicines Initiative, amongst other organization. She is a consultant child and adolescent psychiatrist in the Maudsley-based Service for Complex Autism and Associated Neurodevelopmental Disorders, funded by NHS England to see children and young people across the southern region with complex presentations.

Professor emeritus of Psychotherapy at the Department of Child and Adolescent Psychiatry, Psychosomatic and Psychotherapy, Medical Faculty
and Faculty of Human Sciences of the University of Cologne, Germany.

Professor Dr. Doepfner began his career with a Psychology degree at the University of Mannheim. Germany. In 1990, he received his doctorship from the University of Heidelberg’s Faculty of Medicine. He is supervisor of behaviour therapy and Head of the School or Child and Adolescent Cognitive Behavior Therapy (AKiP) at the University of Cologne. He received the German Psychology Prize for his scientific work in 2005.

His main research interests are assessment, prevention, and treatment of ADHD, Conduct Disorders, Anxiety Disorders, Obsessive-Compulsive Disorders and Tic Disorders. He is principal investigator of several multicentre trials on pharmacotherapy and psychotherapy of ADHD and conduct disorders, of prevention studies for externalizing problem behaviour in children, and on self-help-interventions for parents of children and adolescents with ADHD/ODD.

Prof. em. Manfred Doepfner, PhD
Department for Child and Adolescent Psychiatry, Psychosomatic and Psychotherapy
School for Child and Adolescent Cognitve Behavior Therapy
University of Cologne
Pohligstr. 9, D-50969 Koeln, Germany
manfred.doepfner@uk-koeln.de
 

Diane Purper-Ouakil is professor of child and adolescent psychiatry at the university hospital of Montpellier, France. Since 2011, she is head of the child and adolescent unit of the Saint Eloi Hospital. This unit has facilities for both inpatient and outpatient care for young patients and has specialized services for children and adolescents with ADHD and eating disorders.
She is also vice-president of the faculty college of psychiatry involved in the ongoing reform of the training curriculum of medical studies and is member of the professional college of psychiatrists. 
Diane Purper-Ouakil aims to develop the evidence-base of psychological, neurophysiological and pharmacological treatments, especially for children and adolescents with challenging and enduring behavioural and emotional symptoms. She is involved in collaborative treatment studies, some assessing parent programs, an important feature of comprehensive treatment plans for young people with complex needs.